Bio-Path Holdings Reports First Quarter 2012 Operational and Financial Results – Quarter Highlighted by Progress with Lead Product Candidate, Liposomal Grb-2

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ